Search Results 161-170 of 18465 for Relapse
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Even though several psychological and pharmaceutical treatments are available for addiction, as many as 75% to 98% of patients relapse. "What's unique about ...
About this study. RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Clinical Trials · Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia · More about research at Mayo ...
PMBCL carries the risk of the cancer coming back after treatment, known as a relapse. Most relapses happen within the first two years after treatment. The ...
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 ... Inadequate response, relapse, and/or ...
... relapsed or refractory low-grade follicular lymphoma, Waldenstrom macroglobulinemia, or mantle cell lymphoma. Participation eligibility. Participant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.